当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析

万邦医药

(301520)

  

流通市值:8.02亿  总市值:32.08亿
流通股本:1666.67万   总股本:6666.67万

万邦医药(301520)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.30亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益149369.68万元,未分配利润35653.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产156880.00万元,负债7510.32万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入90,172,342.02341,806,532.85240,653,628.05164,992,422.62
营业总成本65,349,751.67230,811,694.31159,525,538.79104,625,082.21
营业利润32,127,485.39119,006,174.3485,574,889.7160,480,601.02
利润总额32,375,766.77119,644,908.2885,943,354.5860,701,232.51
净利润29,687,084.26108,091,849.3177,311,464.5353,820,558.48
其他综合收益--0-
综合收益总额29,687,084.26108,091,849.3177,311,464.5353,820,558.48
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,376,735,121.421,362,183,442.361,338,570,961.69295,434,512.93
非流动资产合计192,064,874.89182,405,946.67179,625,574.91169,660,895.97
资产总计1,568,799,996.311,544,589,389.031,518,196,536.6465,095,408.9
流动负债合计57,826,672.5266,935,729.7772,331,560.2668,538,022.45
非流动负债合计17,276,480.9413,643,900.6712,635,602.5311,119,815.18
负债合计75,103,153.4680,579,630.4484,967,162.7979,657,837.63
归属于母公司股东权益合计1,493,696,842.851,464,009,758.591,433,229,373.81385,437,571.27
股东权益合计1,493,696,842.851,464,009,758.591,433,229,373.81385,437,571.27
负债和股东权益合计1,568,799,996.311,544,589,389.031,518,196,536.6465,095,408.9
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计77,696,322.08323,773,546.43227,101,965.12153,359,088.89
经营活动现金流出小计77,130,116.07251,848,763.89177,626,783.1117,681,075.54
经营活动产生的现金流量净额566,206.0171,924,782.5449,475,182.0235,678,013.35
投资活动现金流入小计-356,715,349.96128,757,260.74256,986,031.64
投资活动现金流出小计15,317,843.651,389,415,974.8346,787,396.91308,227,282.21
投资活动产生的现金流量净额-15,317,843.65-1,032,700,624.84-218,030,136.17-51,241,250.57
筹资活动现金流入小计-1,052,940,021.041,052,940,021.04-
筹资活动现金流出小计-24,821,954.7318,864,074.9830,000
筹资活动产生的现金流量净额-1,028,118,066.311,034,075,946.06-30,000
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-14,751,637.6467,342,224.01865,520,991.91-15,593,237.22
期末现金及现金等价物余额238,745,336.87253,496,974.511,051,675,742.41170,561,513.28
TOP↑